LSBCF
LakeShore Biopharma Co., Ltd.
$0.07
+0.00 (+0.00%)
At close · Jun 29
Market Cap
$2.76M
Shares
41,212,693
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.07
Open$0.07
Day$0.07–0.07
52W$0.03–1.48
Avg vol 30d6K
Short int4K · 0.0% float · 1.0d
Short vol100%
DataMar 2023–Jun 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−85% below
+
Price vs 50-day avg
+22% above
◦
RSI (14)
52 · neutral
−
MACD trend
negative
−
52-week position
3% · near low
Sentiment · smart money
Bearish
◦
Trend (MA cross)
50d $0 › 200d $0 — 200d above 50d
−
Institutional flow
-88% holders QoQ
◦
Insider flow
No net insider activity over 90 days
◦
Short interest
0.01% of float · ▬ 0.0% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
1 holders — near 1-yr low, contrarian setup
Fundamentals
Strong
◦
Revenue growth
+6% Y/Y
+
Gross margin
82%, expanding
+
EPS growth
+87% Y/Y
−
Free cash flow
$-18.6M
+
Balance sheet
net cash $22.4M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ2-27 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−85% below
Bearish
Price vs 50-day avg
+22% above
Bullish
RSI (14)
52 · neutral
Neutral
MACD trend
negative
Bearish
52-week position
3% · near low
Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
-88% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.01% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 1-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $0
Now $0 · 3%
52-wk high $1
vs 200-day avg -85%
vs 50-day avg +22%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LSBCF
this stock
LakeShore Biopharma Co., Ltd.
|
$2.76M | -92.0% | +6.0% | — | 0.0% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
1
- % held
- 0.1%
- Net QoQ
- -298.7K sh
- Top holder
- BARCLAYS PLC
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LSBCF | +0.0% | -16.3% | -92.1% | -33.0% | -92.0% |
| SPY | -0.5% | -2.1% | +7.8% | -2.1% | +8.7% |
| vs SPY | +0.5% | -14.2% | -99.8% | -31.0% | -100.7% |